Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02688140
Title Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia (TUD-APOLLO-064)
Acronym TUD-APOLLO-064
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Technische Universität Dresden
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | FRA | ESP | DEU


No variant requirements are available.